Home
> SARS-COV-2
SARS-COV-2
Coronavirus: AstraZeneca begins phase III trials for AZD1222 vaccine with help of the US
AstraZeneca is developing the coronavirus vaccine with the help of experts from the University of Oxford.
Uber updates policy to address passengers who choose not to wear masks
Uber elaborates more on the procedure wherein it will not require the mask verification for all of its customers.
Experts warn against dangers of herd immunity approach against COVID-19
Dr. Scott Atlas of the White House Coronavirus Task Force was called out for supposedly considering a herd immunity plan against SARS-CoV-2.
Coronavirus: Cutting-edge face mask from LG promises comfort, reliable performance
Currently, 2,000 units of this advanced face mask are being used by staff at the Severance Hospital in Seoul, South Korea.
Experts raise questions regarding herd immunity as cases in Brazil drop
Others postulate that the human immune system can possibly react differently during a live outbreak such as the 2019 novel coronavirus.
Coronavirus: COVID-19 survivors continue to struggle with long-term health issues
What worries experts the most is the fact that there is no approved cure or treatment against chronic fatigue syndrome.
Coronavirus: UK test and trace services reveal an upsurge of new infections
So far, the government's contact tracing programme has identified 6,616 individuals who have recently tested positive for SARS-CoV-2.
Latest study shares promising results regarding COVID-19 immunity
Results from several immunity studies indicate that the human immune system would likely benefit from vaccination.
Depression cases doubling in the UK amid pandemic: Office for National Statistics
As shown by the information, the rate shot up when lockdowns were imposed across the globe due to the coronavirus outbreak.
Bitcoin: Pandemic pushes price to record high for 2020 as investors turn to cryptocurrency
While every other industry is reporting sluggish sales and trading, the blockchain market continues to report substantial growth.
UK virus vaccine trials see more than 100k volunteers sign up amid plans to scrap PHE
The individuals volunteered in the span of four weeks, which the majority of people view as impressive considering the risks involved.
Coronavirus: Yale's new testing method gets emergency use authorisation from FDA
Surprisingly, Yale School of Public Health intends to share to keep it open-source so that other laboratories can also perform the tests.
Coronavirus: NIAID might approve human challenge trials as 'contingency plan'
While there have been promising developments in the past few weeks related to COVID-19 vaccines, experts warn against complacency.
Coronavirus: Gilead Sciences facing inquiry into alleged remdesivir overpricing
Remdesivir, which reportedly improved the recovery rate of patients has been approve by the FDA for emergency use.
Virus antibody treatment could potentially save lives until vaccine becomes available: Experts
Until a vaccine successfully completes testing and is approved by regulators, alternate forms of treatment are being considered.
Coronavirus NHS test and trace programme shows increasing number of cases in UK
Contact tracing and other preventive measures continue to be the best course of action until a medical breakthrough becomes available.
China willing to cooperate with WHO plans to investigate origins of SARS-CoV-2
For now, the WHO did not specify the identities of the two experts given the ongoing tensions between China and the United States.
Virus pandemic also takes its toll on mental health of healthcare workers, experts worry
These have been observed by researchers in doctors, nurses, emergency responders, law enforcement, and others who have faced the crisis head-on.
Face masks continue to confuse even the top facial recognition systems, say researchers
With a face mask on, the error rate of facial recognition systems increase to five in every 100 cases from three in every 1,000 cases, according to the NIST.
UK govt securing 60mn more doses of virus vaccine from two pharmaceutical firms
Once the coronavirus vaccine is approved for use, the British government plans to prioritise those in the social services and healthcare sectors.
Coronavirus: Florida man with hearing problem creates masks for lip readers
The 53-year old reportedly gradually lost his hearing due to a rare genetic disorder called osteogenesis imperfecta (brittle bone disease).
Moderna to start phase 3 trials of vaccine next week after favourable results in preliminaries
Moderna is closely working with National Institutes of Health and its National Institute of Allergy and Infectious Diseases.
Coronavirus: Healthcare systems switching to new rapid testing platform amid growing cases
This development arrives shortly after UK health officials were criticised by the public for their apparent shortcomings amid the pandemic.
COVID-19: Israeli doctor might be first documented case of coronavirus reinfection
Even White House health adviser Dr. Anthony Fauci is uncertain about how long coronavirus antibodies can protect against exposure.
iMASC: MIT researchers develop reusable mask with replaceable N95 filters
The timing of its announcement is interesting now that the surging number of cases is resulting in shortages of personal protective equipment.
CDC issues new update regarding coronavirus testing and isolation protocols
Following the directions listed by the federal agency should address problems such as shortages of protective equipment and testing kits.
Studies eyeing diet as possible factor affecting risk of death from COVID-19
It is speculated that the abundance of dietary antioxidants brought about by probiotics helps the body defend against the 2019 novel coronavirus.
Coronavirus: Pittsburgh-based company to use innovative cutting-edge drones for disinfection
According to the Aeras Fog Company – a Wexford, Pittsburgh-based startup – the process relies on electrostatic technology.
Coronavirus vaccine might not be ready before holidays, according to health experts
In a statement he gave to the Commons Health and Social Care Select Committee, Professor Whitty expressed that he was 'cautiously optimistic'.
Results of Oxford coronavirus vaccine phase one trials are in; findings are promising
What sets it apart from other candidates is how it stimulates the production of not only the required antibodies but cytotoxic T cells.